Investigating the morphological, mechanical and degradation properties of scaffolds comprising collagen, gelatin and elastin for use in soft tissue engineering by Grover, CN et al.
 1
Investigating the morphological, mechanical and degradation properties of 
scaffolds comprising collagen, gelatin and elastin for use in soft tissue 
engineering 
 
Chloe N. Grovera*, Ruth E. Camerona, Serena M. Besta  
 
a Department of Materials Science and Metallurgy, Cambridge Centre for Medical 
Materials, University of Cambridge, Pembroke Street, Cambridge CB2 3QZ, UK 
 
Email: Chloe Grover (cng21@cam.ac.uk) 
*Correspondence: Chloe N. Grover, Department of Materials Science and Metallurgy, 
Cambridge Centre for Medical Materials, University of Cambridge, Pembroke Street, 
Cambridge CB2 3QZ, UK.  Telephone: +44 1223 362966, Fax: +44 1223 334366. 
 
 2
Abstract  
Collagen-based scaffolds can be used to mimic the extracellular matrix (ECM) of soft 
tissues and provide support during tissue regeneration.  To better match the native 
ECM composition and mechanical properties as well as tailor the degradation 
resistance and available cell binding motifs, other proteins or different collagen types 
may be added.  The present study has explored the use of components such as gelatin 
or elastin and investigated their effect on the bulk physical properties of the resulting 
scaffolds compared to those made from pure collagen type I.   The effect of altering 
the composition and crosslinking was evaluated in terms of the scaffold structure, 
mechanical properties, swelling, degradation and cell attachment.  Results 
demonstrate that scaffolds based on gelatin had reduced tensile stiffness and 
degradation time compared with collagen.  The addition of elastin reduced the overall 
strength and stiffness of the scaffolds, with electron microscopy results suggesting 
that insoluble elastin interacts best with collagen and soluble elastin interacts best 
with gelatin.  Carbodiimide crosslinking was essential for structural stability, strength 
and degradation resistance for scaffolds of all compositions.  In addition, preliminary 
cell adhesion studies showed these highly porous structures (pore size 130–160 μm) 
to be able to support HT1080 cell infiltration and growth.  Therefore, this study 
suggests that the use of gelatin in place of collagen, with additions of elastin, can 
tailor the physical properties of scaffolds and could be a design strategy for reducing 
the overall material costs.  
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1. Introduction 
Due to the limited availability of donor organs and tissues, intensive research has 
been conducted into the use of tailor-made biomaterials in tissue regeneration.  
Engineered tissue should have the capacity to become structurally integrated with the 
native tissue, providing support during the regeneration process but being able to 
biodegrade after it has served its function (Liu et al. 2007).  ‘Smart’ biomaterials must 
provide an environment similar to the native extracellular matrix so as to encourage 
cells to generate new tissue and enhance repair.  The requirements of such a scaffold 
are: 1) highly porous structures to allow cell and nutrient infiltration, 2) similar 
mechanical properties to the native tissue, 3) the ability to degrade to non-toxic 
products and 4) biocompatibility, allowing cells to attach and proliferate.   
 
Scaffolds frequently used in tissue engineering have compositions based on the native 
extracellular matrix of soft tissues i.e. containing both collagen and elastin (Lee, 
Singla et al. 2001; van Luyn et al. 2002; Buttafoco et al. 2005; Xiang et al. 2006; 
Daamen et al. 2007; Daamen et al. 2008).  Collagen typically gives the tissue its 
mechanical strength and stiffness, while elastin can provide elasticity and the ability 
to store elastic-strain energy.  Collagen’s relatively high tensile strength and stiffness 
(120 MPa and 1.2 GPa respectively when hydrated (Gosline et al. 2002)) means that 
even small changes in its concentration, type, crosslinking and spatial alignment in 
the ECM can lead to large effects on the mechanical properties of the tissue.   Our 
research is concerned with myocardial engineering.  Heart muscle has been shown to 
contain approximately 75–90% collagen and up to 25% elastin (dry weight), where 
the collagen is 60–85% type I and 15–40% type III (Lowry et al. 1941; Weber 1989; 
Bishop et al. 1990; Mukherjee and Sen 1991, 1993; Marijianowski et al. 1995; de 
Souza 2002).   It should be noted, however, that each tissue has its own set and 
content of proteins and biomolecules, and thus attention should be paid to combining 
the appropriate proteins to provide the optimal physical properties and 
microenvironment for cells. Various different materials have been used to produce 
scaffolds for cardiac tissue engineering; collagen type I (van Luyn et al. 2002; 
Zimmermann et al. 2002), collagen and glycosaminoglycans (Xiang et al. 2006), 
gelatin (Gelfoam) (Li et al. 1999) and polymers (Fujimoto et al. 2007; Hidalgo-
Bastida et al. 2007; Engelmayr et al. 2008).  However, little consideration has been 
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given to how the composition or crosslinking may affect the physical properties of the 
scaffold.  
 
The impairment of cardiac function with disease is associated with a change in the 
ECM composition, specifically the collagen content, crosslinking and type (Bishop et 
al. 1990; Norton et al. 1997; Debessa et al. 2001; Yamamoto et al. 2002; Koshy et al. 
2003).  Therefore we have chosen to investigate scaffolds based on type I collagen 
with/without 10% elastin (a lower bound for elastin composition in the heart) such 
that the elastin content may provide our scaffolds with a resilience and distensibility 
usually provided by type III collagen (Weber 1989; Fung 1993; Pauschinger et al. 
1999; de Souza 2002).  Our choice of elastin rather than type III collagen was also 
one of economical significance: currently, type III collagen is nearly 5000 times the 
cost of type I collagen (website Sigma Aldrich).  This also led to our investigation of 
gelatin as a potential scaffold base; a thermally denatured collagen, easier to extract 
and prepare and thus more practical to use (Rosellini et al. 2009).  The thermal 
denaturation may alter the physical properties of the material as well as the available 
cell bindings sites (Kozlov and Burdygina 1983; Elliott et al. 2002).  It has also been 
discussed that enhanced collagen crosslinking can lead to stiffening of soft tissues.  
Crosslinking using carbodiimides, such as 1-ethyl-3-(3-dimethylaminopropyl) 
carbodiimide hydrochloride (EDC),  is via carboxylic acid and amine groups on the 
proteins (both collagen and elastin) and has been shown to increase their degradation 
stability and mechanical properties (Jorge-Herrero et al. 1999; Hafemann et al. 2001; 
Buttafoco et al. 2005; Chiu et al. 2010).  In the production of crosslinked scaffolds, 
the degree of crosslinking should be sufficient to provide resistance to degradation but 
not to exceed the mechanical properties of the native myocardium.  
 
In this paper we test the hypothesis that varying the protein composition of scaffolds 
can provide a means of tailoring their mechanical and degradation properties.  The 
overall aim was to investigate the cost-effective production of a scaffold, composed of 
combinations of macromolecules found in the ECM, with suitable structural, 
mechanical and degradation properties for use in myocardial tissue engineering.  The 
potential for the development of a scaffold with structural integrity, bulk composition 
and mechanical properties similar to heart tissue (Young’s modulus of 10–150 kPa in 
the physiological regime (Nagueh et al. 2004; Alter et al. 2008; Engelmayr et al. 
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2008; Zhong et al. 2009; Wang et al. 2010)) was investigated.  Cell adhesion was also 
studied as a preliminary test to provide initial insight into whether a scaffold 
optimised for its physical properties could be used as a vector to deliver cells.  Further 
work into the cell reactivity of these biomaterials is being carried out in our lab.  
These scaffold compositions could easily be tailored to provide tissue-specific 
scaffolds suitable for use in a range of applications such as dermal replacement or 
cartilage repair. 
2. Materials and Methods 
2.1 Materials 
Collagen (bovine dermal type I, Coll) was purchased from DevroMedical, UK.  
Insoluble (IE) and soluble (SE) elastin (both from bovine neck ligament), gelatin 
(type B from bovine skin, Gel), acetic acid (2 M), 1-ethyl-3-(3-dimethylaminopropyl) 
carbodiimide hydrochloride (EDC) and N-hydroxy-succinimide (NHS) were 
purchased from Sigma Aldrich (UK).  Dulbecos Modified Eagles Medium (DMEM, 
Gibco), phosphate buffered saline (PBS, Gibco), Foetal Calf Serum (FCS), penicillin 
and streptomycin were purchased from Invitrogen Life Sciences (UK). HT1080 
human fibrosarcoma cells were obtained from the European Collection of Animal 
Cell Cultures, Porton Down, UK.  Other reagents were all analytical grade, 
commercially available and used as received.   
2.2 Preparation of Mixed Composition Scaffolds 
In total, seven different scaffolds were prepared and are detailed in Table 1.  Briefly, 
collagen with or without (±) elastin were swollen in 0.05 M acetic acid at 4 ± 2°C 
overnight to produce a 1% (w/v) protein suspension.  The resulting suspension was 
homogenised on ice for 10 min at 9,500 rpm using an Ultra-Turrax VD125 (VWR 
International Ltd, UK).  Air bubbles were removed from the suspension by 
centrifuging at 2,500 rpm for 5 min (Hermle Z300, Labortechnik, Germany). 
 
Gelatin-based slurries could not be prepared by homogenisation. Dissolution of the 
powder required heating and homogenisation at high temperatures resulted in the 
formation of a foam.  However, the solution began to gel at temperatures below 
approximately 15°C, so homogenisation could not be carried out at low temperatures 
either.  Gelatin-based solutions, 1% (w/v), were instead prepared by dissolving gelatin 
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± elastin in 0.05 M acetic acid at 37–45ºC with stirring for 1 hour (h).  The solutions 
were then cooled to room temperature with stirring.  
 
The mixed collagen-gelatin 1:1 suspension was prepared by mixing a gelatin solution 
with a collagen slurry (both 1% w/v), before centrifuging.  All suspensions were then 
poured into silicone trays (Lakeland, UK), to ensure ease of removal, and freeze-dried 
in a VirTis adVantage benchtop freeze-drier (Biopharma Process Systems, UK) using 
a cycle adapted from work by O’Brien et al. and Yang et al. (O'Brien et al. 2005; 
Yang et al. 2005).  A constant cooling rate of 0.9°C/min to a final freezing 
temperature of -26ºC was used.  The temperature was then held constant at -26ºC for 
4 h.  The ice phase was sublimed under vacuum (80 mTorr) at 0ºC over 27 hours.   
 
2.3 Chemical Crosslinking 
Scaffolds were chemically crosslinked using a water-soluble carbodiimide to increase 
their strength and degradation resistance.  The carboxylic acid groups on the collagen, 
gelatin and elastin were activated by 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide 
hydrochloride (EDC) in the presence of N-hydroxy-succinimide (NHS), so as to 
reduce the number of side reactions and therefore induce crosslinking with free 
primary amine groups (Pieper et al. 1999).  Crosslinking was carried out with 1.150 g 
EDC and 0.276 g NHS per gram of scaffold (molar ratio EDC:NHS 5:2, as described 
in (Olde Damink et al. 1996)), using ethanol/water (75% v/v) as a solvent (Buttafoco  
et al. 2005; Xiang et al. 2006).  After reaction for 2 h at room temperature, the 
scaffolds were washed twice in ethanol/water (75% v/v) followed by three times in 
deionised water for 30 min each before subsequent freeze-drying (as previously 
described in 2.2). 
 
The change in pore size, volume and mass, due to crosslinking, were evaluated after 
freeze-drying using the following equations:  
Volume Shrinkage (%) = 100 x {(V0 – V)/V0} 
where V0 is the volume of the scaffold before and V is the volume after crosslinking; 
Mass Loss (%) = 100 x {(m0 – m)/m0}  
where  m0 is the mass before and m is the mass after crosslinking. 
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The degree of scaffold crosslinking was assessed by determination of the amine group 
content of the scaffolds spectrophotometrically after using 2,4,6-trinitrobenzene 
sulfonic acid (Olde Damink et al. 1996). 
 
2.4 Characterisation of the Scaffolds 
2.4.1 Scanning Electron Microscopy (SEM) 
SEM was used to analyse the scaffold morphology (pore size and porosity, as well as 
the interaction between components).  Each sample was cut through the thickness of 
the scaffold (approximately 4–8 mm), as well as sectioning them in half (parallel to 
the top surface).  Scaffold samples (cross-section, top and bottom surfaces) were 
mounted on stubs and sputtered with an ultrathin layer of platinum for 2 min at 
20 mA.  The scaffolds were studied with a JEOL-820 scanning electron microscope 
operating at 10 kV. 
 
Image data was imported into ImageJ software for analysis.  The average pore size 
was obtained by measuring the maximum and minimum diameter of 10 pores chosen 
at random throughout the central section of the samples, whilst the porosity was 
determined by calculating the fraction of the total area occupied by pores per image.    
 
2.4.2 Mechanical Properties 
Stress-strain analysis of scaffolds in tension and compression were performed by 
uniaxial measurements using a Hounsfield tester, equipped with a 5 N load cell.  Tests 
were repeated for 9–12 samples to obtain mean data. 
 
2.4.2.1 Tensile Tests 
Rectangular sections were cut with a cross-sectional area of approximately 7 x 4 mm 
and hydrated in deionised water at room temperature for 1 h prior to testing.  They 
were then clamped vertically, with a gauge length of 10 mm and tested at a constant 
rate of 6 mm min-1.  The thickness and width of the samples were measured 
accurately at three different positions using electronic callipers.  All samples were 
stretched until failure.  Stress was calculated by dividing the force generated during 
extension by the initial cross-sectional area. 
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The resulting stress-strain curves were used to calculate the Young’s modulus (E) and 
stress at 20% strain (σ), and the failure strain for each of the different scaffold 
compositions.  
 
2.4.2.2 Compression Tests 
All compression tests were performed perpendicular to the plane of the scaffold disc.  
Cylindrical punches, of 5 mm diameter and thickness of 4–8 mm, were taken of the 
scaffolds and hydrated in deionised water at room temperature for 1 h prior to testing.  
The impermeable, unlubricated compression platens were lowered so as to contact the 
sample and produce a small, but detectable load (0.002 N).  Samples were then 
compressed at a rate of 6 mm min-1 until a sharp increase in stress was detected 
(densification of the sample) when the tests were stopped.  Stress-strain curves were 
plotted and used to calculate the compressive modulus and stress at a strain of 20% 
(to enable comparison with tensile data).  
2.4.3 Swelling and Degradation Study 
Due to the formation of intermolecular bonds, the fluid-binding capacity and 
degradation kinetics of the scaffolds are affected by crosslinking.   Phosphate buffered 
saline (PBS, pH 7.4), a relevant biological buffer, was used in both swelling and 
degradation experiments. Tests were repeated with four parallel samples each.  
2.4.3.1 Swelling and Fluid Uptake 
Cylindrical samples (diameter 5 mm) were submerged in 1–2 ml PBS and incubated 
at 37 ºC for up to 14 days (d).  After different time intervals (1 h, 24 h, 3 d, 7 d, 10 d, 
14 d) samples were removed and the wet weight (mw) and swollen weight (after 
drying between filter paper, msw) were determined.  Scaffolds were then dried in a 
vacuum oven at 37 ºC until constant mass was reached (md), and two different 
measurements of their capacity to retain water were made:  
1.  The ability of the scaffold structure to absorb fluid (the material and the pores) 
Fluid uptake of scaffold (%) = 100 x {(mw – md) / md} 
2.  The swelling ability of the scaffold material itself (PBS from pores is removed) 
Fluid uptake of scaffold material (%) = 100 x {(msw – md) / md} 
The pH value of the PBS was measured after each time point using a pH meter.   
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2.4.3.2 Degradation Study 
Cylindrical samples were weighed (mp) and submerged in PBS as above. After 
different time intervals (1 h, 7 d and 14 d) samples were washed in a large volume of 
deionised water to remove buffer salts and dried on filter paper to remove excess 
water before freeze-drying.  The final mass was recorded (md) and used to calculate 
the percentage weight loss: 
Weight loss (%) = 100 x {(mp – md)/ mp} 
 
SEM images of scaffolds were used to analyse the change in pore size, and 
compression testing was performed at each time interval.  These tests were repeated 
with four parallel samples each. 
2.4.4 Cell Adhesion Study 
HT1080 cells derived from a human fibrosarcoma were used in this study as they are 
an adherent cell line that express general collagen-binding integrins and therefore are 
expected to adhere to our scaffolds.  Scaffolds were cut to approximate cuboids 
(7 x 7 x 5 mm) and sterilised by washing twice with 75% ethanol (10 min), rinsed 
three times with deionised water (10 min) and then washed with PBS before 
incubating with 0.5 ml supplemented-DMEM (10% FCS, 100 μg/ml penicillin and 
100 μg/ml streptomycin) for 30 min at 37ºC.  This medium was then removed and 105 
HT1080 cells in 100 µl medium were seeded onto the scaffold cross-section and 
incubated for 20 min to allow them to attach.  Scaffolds were then inverted and a 
further 105 cells in 100 µl medium were seeded onto the opposite surface.  After a 
final 20 min incubation to allow cell attachment, 1 ml DMEM was added for culture 
for 3 d at 37 ºC under 5% CO2. 
 
After culture, scaffolds were rinsed with PBS (200 µl) and fixed with 4% 
paraformaldehyde in PBS (200 µl) for 30 min at room temperature, and finally 
washed three times with PBS.  SEM images of the cell-seeded scaffolds were then 
taken. 
2.4.5 Statistical Analysis 
Results are expressed in the figures as mean ± standard error measurement.  Student’s 
t-test was used to compare differences among mean values of physical properties and 
post-hoc comparisons used Student Newman Keuls.  Crosslinked samples were 
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compared with non-crosslinked samples of the same composition and a significant 
difference of p  ≤ 0.05 was denoted by *.  Additionally, different composition were 
compared and a ? indicates significant difference between compositions for statistical 
significance of p  ≤ 0.05. 
 
3. Results 
3.1 Scaffold Synthesis and Morphology 
3.1.1 Synthesis 
Samples produced were white in colour and had a porous structure that was encased 
in a film-like surface layer and base layer with a much smaller pore size.  However, 
phase separation was noted in gelatin-insoluble elastin samples, where the dense, 
insoluble elastin fibres sank to the base of the scaffold and could be visually identified 
by their thick, fibre-like appearance and yellow colour.  This was not observed in 
collagen-insoluble elastin samples, or samples containing soluble elastin.  Although 
phase mixing to produce a homogeneous structure may have been expected for all 
samples, the effective mixing of components was only seen for collagen-insoluble 
elastin, gelatin-soluble elastin and collagen-gelatin scaffolds as depicted by the 
illustrations in Fig. 1. 
3.1.2 Morphology and Effect of Crosslinking 
The freeze-drying of slurries created matrices in which the pore size, shape and 
porosity varied throughout the cross-section in both crosslinked and non-crosslinked 
samples of all compositions.  This change in pore shape and size is shown clearly in 
the SEM image of a crosslinked collagen scaffold (Fig. 2): larger pores in the central 
region (b), which decrease in diameter towards to bottom of the scaffold (c).  The 
scaffold composition has little effect on the morphology of this central region, with a 
pore size of 130–160 µm and porosity of 65–75%.  It should also be noted that the 
pore size and porosity also differ at the surfaces of the scaffolds (Fig. 2 d and e), with 
a film-like layer (porosity 15–30%) forming on the top surface and smaller pores on 
the bottom surface (60–110 µm, porosity 50–60%).  
 
When scaffolds were crosslinked in ethanol/water (75% w/v) using EDC/NHS and 
subsequently freeze-dried, a porosity of approximately 70% was obtained, 
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significantly reduced compared with 90% before crosslinking and scaffolds shrank to 
up to 80% of their original volume (Table 2).  These results are comparable to those 
for collagen scaffolds presented by other groups (Buttafoco et al. 2005 and Davidenko 
et al. 2010).  The mass loss that occurred during the crosslinking process was only 
significant for collagen-soluble elastin scaffolds (11%, Table 2).  
 
The physical mixing and interaction of elastin with collagen and gelatin can be seen 
in the SEM images and illustrations (Fig. 1, 3 and 4).  At higher magnification, 
collagen fibre bundles of diameter 0.82 ± 0.16 µm can be seen within the sample 
cross-section (Fig. 3a, 4a).  The gelatin samples were produced from a solution rather 
than fibrous suspension and thus the lack of fibres in the SEM images is to be 
expected (Fig. 3b, 4c).  The insoluble elastin fibres (diameter 5.4 ± 0.84 µm) are 
homogeneously distributed throughout the collagen scaffold, although they tended to 
clump together in bundles containing up to ten elastin fibres (diameter 
14.8 ± 1.59 µm).  However, insoluble elastin sank to the bottom of gelatin scaffolds 
and was only visible in the SEM images of the bottom surface of the scaffold.  There 
are no distinct phase-separated regions within the gelatin-soluble elastin scaffold (Fig. 
4c), however globules of soluble elastin could be seen on the collagen fibres in both 
non-crosslinked and crosslinked samples (Fig. 4 a and b). 
 
The value of free amine groups in all samples after crosslinking is lower than that 
prior to crosslinking, in the range of 4−9 x10-5 mol/g (Table 3).  Collagen-based 
scaffolds showed a significantly lower degree of crosslinking (45−60%) compared 
with gelatin-based scaffolds (60−78%, p ≤ 0.05).  The non-crosslinked gelatin 
scaffolds had a higher number of free amine groups than the collagen samples.   
3.2 Mechanical Testing 
With regard to the physiological loading conditions of soft tissues, the mechanical 
properties of the scaffolds were examined in terms of their tensile modulus and 
strength at 20% strain (within the physiological regime of heart tissue (Nagueh et al. 
2004; Alter et al. 2008; Wang et al. 2010)) and failure strain.  Preliminary tests 
conducted on non-crosslinked scaffolds were unsuccessful due to low failure stresses 
and the difficulty of handling hydrated, non-crosslinked scaffolds.  All subsequent 
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tests were conducted with fully hydrated, crosslinked scaffolds at room temperature 
and a rate of 6 mm min-1.   
3.2.1 Tensile Tests 
The tensile stress-strain curves are typical of biological materials, in that they are all 
non-linear and J-shaped (Fig. 5), similar to those found for native extracellular matrix, 
in particular, myocardium (Nagueh et al. 2004; Wang et al. 2010).  A comparison of 
the curves indicates that at low strains they follow that of native myocardium closely, 
but at strains greater than 10% the stiffness of the biomaterial scaffolds did not 
increase as rapidly.  Since heart tissue operates in the physiological regime of up to 
20% strain (Nagueh et al. 2004; Alter et al. 2008; Wang et al. 2010), and in order to 
easily compare results between different compositions, the stress and modulus were 
recorded at this point.   
 
Scaffolds containing a higher percentage of collagen had a higher Young’s modulus 
and strength at 20% strain (Table 4).   The addition of less rigid elements, such as 
elastin or gelatin, reduces its stiffness to produce a curve that more closely matches 
that of the native myocardium in the low strain region.  The use of gelatin alone 
produces a scaffold suitable at very low strains (less than 0.05%) but whose strength 
does not increase in line with that of the myocardium.  The addition of elastin had a 
similar effect on both collagen and gelatin scaffolds in that there was a slight increase 
in strain at failure.  These recorded strains at failure are underestimates due to the 
majority of scaffold failure occurring at the grips.  
3.2.2 Compressive Tests 
Distinct collapse plateau and densification regimes can be seen in the stress strain 
curves for scaffolds tested in compression (Fig. 6), regardless of the scaffold 
composition.  These regions are characteristic of low density, open-cell foams (Harley 
et al. 2007).  The initial linear elastic region is hard to identify, and it is likely that 
strut buckling and collapse occur at the same time.   
 
In order to standardise the results, a comparison of the compressive modulus (E) and 
strength at a fixed strain (20%) was performed.  The modulus and strength of the 
collagen-based scaffolds were reduced when tested in compression compared with in 
tension: for crosslinked collagen Et=81 kPa whereas Ec=2.9 kPa and σt=7.8 kPa 
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whereas σc=0.4 kPa. In contrast, those properties of the gelatin-based scaffolds did 
not change significantly: for crosslinked gelatin Et=4.6 kPa whereas Ec=4.25 kPa and 
σt=0.75 kPa whereas σc=1.0 kPa. The addition of elastin to either collagen or gelatin, 
resulted in a scaffold with reduced compressive strength and stiffness and a slight 
increase in strain at failure, as seen when testing in tension (Fig. 6). 
3.3 Swelling and Degradation of Scaffolds 
Effects of crosslinking and composition on the water binding capacity, swelling 
ability and degradation kinetics of the scaffolds were measured, as well as their 
mechanical properties in compression and pore structure.   
 
3.3.1 Structure and Stability 
The structural integrity of the scaffolds after water-uptake and degradation studies 
was confirmed by analysing the pore structure of samples, which were freeze-dried 
after incubation in PBS for 7 and 14 days.  Initial observations of the scaffolds 
showed that non-crosslinked gelatin samples dissolved after less than an hours 
incubation in PBS. Whilst non-crosslinked collagen scaffolds survived incubation, 
after drying between filter paper to remove pore fluid the scaffolds collapsed; a stable 
structure could not be obtained even after rehydration.  This meant that for non-
crosslinked scaffolds, pore size analysis could not be conducted.  Crosslinked 
scaffolds, however, showed no significant change in pore size after incubation in PBS 
for 14 days (results not shown).   
 
3.3.2 Swelling and Fluid Uptake 
The fluid binding capacity indicates the absorption of cell culture medium or 
physiologically relevant buffers during culture of cells.  The PBS uptake of the 
scaffold structure and that of the material, give different measures of the ability of the 
scaffold to bind to fluids.  The results are shown in Fig. 7, where the results for non-
crosslinked gelatin-based samples are missing owing to the fact that these scaffolds 
dissolved after an incubation time of one hour. 
 
Figure 7 shows that increased incubation time allows increased binding of the PBS to 
the scaffold material, demonstrating a time-dependent nature of swelling (Fig. 7 a and 
c).  Although crosslinking results in a significant (p ≤ 0.05) reduction of fluid uptake 
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by the scaffold material compared with non-crosslinked scaffolds, an increase in fluid 
uptake by the scaffold as a whole is seen (Fig. 7 b and d).    The uptake of PBS into 
the bulk scaffold is found to be independent of time, with fluid uptake into the pores 
occurring almost instantaneously (represented by a single column on the graphs).  For 
the scaffold itself, the hydrophilic nature of the material is likely to affect the quantity 
of PBS taken up by the scaffold material.   Figure 8 shows that gelatin-containing 
scaffolds are able to take up more fluid into the material compared with the collagen 
scaffolds.  A reduction in pH (from 7.4 to 6.5–6.8) was noted over the course of the 
study for all samples.  After approximately three days this pH value reached a plateau 
and remained almost unchanged for the duration of the study.   
3.3.3 Degradation Study 
Degradation is likely to occur by dissolution of the scaffold struts exposed to PBS.  
The pore size of crosslinked scaffolds did not change, confirming that extensive 
degradation of the scaffold struts has not occurred.  Mechanical properties of 
degrading samples were investigated in unconfined compression tests, using hydrated 
scaffolds. These tests could not be conducted on non-crosslinked samples due to the 
difficulty of handling the samples once hydrated (lack of structural stability). 
 
It was found that: (1) The non-crosslinked gelatin-based scaffolds showed much faster 
degradation kinetics than all other scaffolds, with complete dissolution noted after 
incubation for 1 hour in PBS. (2) The greatest mass loss after 14 days was noted for 
the non-crosslinked samples (40% for collagen ± elastin scaffolds, up to 85% for 
collagen-gelatin samples and 100% for gelatin samples, data not shown). 
(3) Crosslinked scaffolds had a maximum mass loss of up to 15% for collagen-based 
and 25% for gelatin-based (Fig. 8). (4) The effect of adding elastin to collagen or 
gelatin on the scaffold mass loss was not significant within the overall error of the 
experiment (due to small changes in mass). (5) A statistically significant reduction in 
the compressive modulus at 20% strain was noted for all samples (except collagen-
gelatin) over the 14 day incubation period. 
 
The rate of mass loss slowed within the second week of testing (down to 
approximately 1% per day, except for gelatin-soluble elastin), with crosslinked 
samples retaining 75–95% of their original mass.     
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It should be noted that this swelling and degradation study was conducted in PBS (a 
biological buffer) in the absence of enzymes and with a different ionic composition to 
cell culture medium.  It is known that collagen is degraded by collagenases and that 
the presence of cells (which secrete enzymes and other biomolecules) may alter the 
degradation kinetics of the scaffolds.  As these scaffolds are intended for in vivo and 
in vitro use, it would be of interest to carry out degradation studies in the presence of 
enzymes or culture medium.   
 
3.4 Cell Adhesion 
Preliminary tests were conducted to establish whether crosslinked scaffolds could 
support cell adhesion and justify any further investigations into their potential use as 
cell delivery vehicles.  These studies were conducted with adherent HT1080 cells, 
seeded onto the cross-section surface of crosslinked scaffold samples and cultured for 
3 days.  Seeding cells onto the cross-section reduced the effect of the surface film 
layer limiting the cell infiltration.   SEM imaging of scaffolds showed that cells 
attached readily to both collagen- and gelatin-based scaffold surfaces, and in most 
cases showed clear spreading and attachment to the scaffold strut surface (Fig. 9).  No 
significant differences in observed cell number were noted between scaffolds of 
different composition, but the 3-dimensional nature of the scaffolds made direct 
comparisons difficult.  Longer-term culture was not investigated: after 3 days of 
culture cells started to form cell-cell contacts; these interactions may alter how the 
cells interact with the biomaterial.  Our group is conducting further research into how 
the cells interact specifically with the biomaterial. 
 
4. Discussion  
The purpose of this study was to investigate the combination of alternative proteins, 
such as elastin (to replace type III collagen) and gelatin (as an alternative to type I 
collagen), for the production of a structurally stable scaffold with physical properties 
similar to that of native extracellular matrix, in particular the myocardium.  Three 
main comparisons were made; crosslinked versus non-crosslinked, collagen versus 
gelatin and soluble versus insoluble elastin, and evaluated in terms of the structural, 
mechanical and degradation properties of the scaffolds. 
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4.1 Non-crosslinked versus crosslinked   
Previous studies into the mechanical stiffness, strength and degradation stability of 
scaffolds have shown that these properties were increased after crosslinking (Jorge-
Herrero et al. 1999; Hafemann et al. 2001; Buttafoco et al. 2005; Geutjes et al. 2007; 
Chiu and Radisic 2010; Chiu et al. 2010; Madhavan et al. 2010).  Tests, conducted in 
this study, also confirmed these results: the mechanical testing of non-crosslinked 
scaffolds was difficult to conduct due to their low strength.  The presence of cross-
links (as confirmed by the TNBS assay) prevents chain sliding, providing mechanical 
strength and additional structural stability.  Degradation studies in PBS demonstrated 
that non-crosslinked scaffolds had maximal mass loss, confirming that crosslinking is 
essential to prevent rapid dissolution/degradation of the scaffolds in aqueous 
environments and maintain their structural integrity.  There is also the possibility of 
varying the degree of crosslinking so as to provide further control over the 
degradation kinetics.   
 
Crosslinking of the scaffolds is required to obtain matrices that would resist 
degradation and mechanically support the heart during the pumping cycle (Jorge-
Herrero et al. 1999; Hafemann et al. 2001; Buttafoco et al. 2005; Chiu et al. 2010; 
Davidenko et al. 2010).  However, the crosslinking process should not alter the 
structure in such a way as to produce a detrimental effect on pore size, composition or 
biocompatibility.  A small mass loss was noted during crosslinking for all scaffolds 
(except pure gelatin) and is likely to be as a result of dissolution of proteins from the 
scaffold struts by the crosslinking solution (Table 2).  However, this mass loss was 
not considered significant, except in the case of collagen-soluble elastin (discussed 
later).  A decrease in pore size of the central region e.g. from 190 to 160 µm for 
collagen and reduction in porosity (to ~ 70%) was also seen during crosslinking 
(Table 2).  This may be as a result of the volume shrinkage and mass loss during 
crosslinking, as well as the formation of inter-fibre bonds.  Some loss of pore 
structure is expected during the crosslinking process (hydration for 2 hours in 
ethanol/water) owing to mass loss and volume shrinkage.  Additionally, the physical 
presence of the cross-links pulls fibres closer together and may cause a further 
reduction in the pore size, resulting in a more dense structure.  The pore size is 
important in allowing cell infiltration, vascularisation and the diffusion of nutrients 
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and oxygen, and the scaffold porosity should be high to prevent obstruction of the 
material, which may lead to necrosis in vivo (Radisic and Vunjak-Novakovic 2005; 
Murphy et al. 2010).  Although crosslinking reduces the pore size, these scaffolds 
were still able to support HT1080 cell infiltration and attachment (Fig. 9) and the pore 
size is within a range suitable for the growth of myocytes, endothelial cells and 
fibroblasts as reported in previous research (Gerdes et al. 1986; Radisic and Vunjak-
Novakovic 2005; Wang et al. 2010).  
 
During synthesis, a film-like layer forms over the top surface (Fig. 2 d) as a result of 
conduction in the freeze-drier (Harley et al. 2007) and a reduced pore size is visible 
on the bottom surface (Fig. 2 e) with occasional large voids (up to 180 µm), likely to 
be as a result of ice nucleation events on the silicone mould.  If these materials were 
to be used for long-term cell culture experiments, the film-like top layer and small 
pore size on the base of the scaffold may act as barriers to nutrient and oxygen 
diffusion and may therefore need to be removed.  Likewise, consideration should be 
given to the volume shrinkage of the scaffolds when crosslinking if these scaffolds are 
to be used for structurally sensitive devices.  Further, it may be beneficial to 
investigate the production of scaffolds with aligned pores (rather than a random pore 
structure) where this specific feature may be favourable, such as in the myocardium.   
 
The hydration of scaffolds is important in indicating how cell culture medium may be 
absorbed during culture and how the scaffold may behave in vivo.  Crosslinking is 
known to reduce the hydrophilic nature of the material since groups involved in the 
binding of water are consumed during the crosslinking process (amino and carboxylic 
acid groups) (Charulatha and Rajaram 2003).  Collagen-based scaffolds showed a 
reduced ability to uptake fluid after crosslinking (Fig. 7 a).  However, due to the 
highly porous nature of the scaffold, the swelling ability of the material itself has little 
effect on the overall fluid retention (Fig. 7 b).  Non-crosslinked scaffolds collapsed 
after incubation in PBS for just 1 hour (with gelatin scaffolds completely dissolving in 
this time period), whereas crosslinked scaffolds showed no significant change in pore 
size after 14 days.  Even though there is a measured mass loss as a result of protein 
dissolution from the scaffold struts, the overall structure of crosslinked scaffolds 
remains stable and therefore they were able to hold more fluid compared with the 
mechanically weak non-crosslinked scaffolds.  In spite of the fact that the pore size 
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and hydrophilic properties of the material may be reduced by the crosslinking process, 
crosslinking appears to be beneficial in achieving good absorption characteristics by 
providing structural stability to the bulk scaffold.   
 
4.2 Collagen versus Gelatin 
Collagen scaffolds showed a fibrous structure (Fig. 3 and 4) which resulted in J-
shaped tensile stress-strain curves: initial large extensions for low applied load, then 
as the load is increased, the stiffness of the material increases due to a progressive 
alignment of the protein fibres (these are in agreement with previous research (Kim 
and Mooney 2000; Wang et al. 2010)).  The gelatin used is produced by alkaline 
treatment of collagen that results in its denaturation and some loss of its triple helical, 
fibrous structure.  It is this fibrous structure that gives collagen its strength and 
stiffness, enabling it to take up most of the load in native tissue (Fung 1993), and 
therefore we may expect that the gelatin samples have reduced tensile properties.  It 
was indeed seen that gelatin samples have less of a J-shape and a lower strength and 
stiffness compared with collagen scaffolds.  It should also be noted that the slight 
increase in the fluid uptake of gelatin scaffolds compared with collagen scaffolds 
(Fig. 10, indicating an increased hydrophilic nature) might have an effect on their 
mechanical properties. 
 
The combination of collagen and gelatin resulted in a well-mixed scaffold (no signs of 
phase separation) whose tensile properties were most similar to that of the native 
myocardium at low strains (< 10%): stiffness at diastole (E=10–20 kPa) or systole 
(E=50–200 kPa (Nagueh et al. 2004; Alter et al. 2008; Engelmayr et al. 2008; Zhong 
et al. 2009; Wang et al. 2010)).  It is the addition of the weaker gelatin that reduces 
the stiffness of the scaffold and brings its properties more in line with those of heart 
tissue.  The 1:1 ratio of collagen to gelatin means that a more practical scaffold can be 
produced that has improved degradation resistance (compared to gelatin alone) and 
mechanical properties that are more suited to myocardial tissue engineering. 
 
Since the scaffold may also be subjected to compressive loads during the pumping 
cycle, compression tests were conducted.  It is likely that although the fibres within 
the collagen structure align and provide added strength in tension, they are weaker in 
compression, where the failure mechanism is likely to be strut buckling and pore 
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collapse. These porous structures are not as resistant to compressive deformation as 
tensile deformation, as found previously with scaffolds of other collagen-based 
composition (Huang et al. 2005). Where the gelatin scaffolds lacked stiffness in 
tension, the absence of stiff fibres allowed mechanical properties to be maintained in 
compression.   Collagen-gelatin scaffolds show greatest promise since they are the 
only scaffold type whose compressive modulus does not vary significantly over the 
14 days testing and thus maintain compressive strength even after degradation (~ 15% 
mass loss, Fig. 8a).  
 
4.3 Insoluble versus Soluble Elastin   
When using elastin as a substitute for type III collagen it must integrate well with the 
type I collagen or gelatin and possibly be able to form interfacial bonds with the 
collagen/gelatin.  It was apparent in two compositions that this was not the case:  
(1) Collagen-soluble elastin, where it is likely that the mass loss during crosslinking 
(11%, Table 2) represents a substantial proportion of the soluble elastin present.  The 
reduced presence of globular soluble elastin in the crosslinked sample (Fig. 4 b and c) 
also confirms this, and indicates that the interaction between collagen type I and 
soluble elastin was not strong enough to retain the elastin within the scaffold (a 
possible lack of formation of inter-fibre bonds).  These scaffolds showed reduced 
mechanical strength in both tension and compression compared with pure collagen 
due to lower protein content.  
(2) Gelatin-insoluble elastin, where it is evident that the insoluble elastin fibres sank 
to the bottom of the scaffold and did not form a well dispersed mixture with the 
gelatin (Fig. 3 b).  It was apparent that these fibres did not contribute to the bulk 
mechanical properties of the scaffold due to a reduced compressive stiffness 
compared with pure gelatin.   
If either of these compositions (Coll-SE or Gel-IE) were to be used to produce a 
scaffold, alternative synthesis methods should be examined in order to produce an 
even dispersion of elastin throughout the scaffold that is retained after crosslinking.  
Good component interactions were seen in Coll-IE and Gel-SE samples; collagen can 
be seen trapping insoluble elastin and connecting separate elastin fibres (Fig. 3a), 
while in gelatin-soluble elastin the absence of obvious interfaces and no significant 
mass loss on crosslinking (only 2%) indicates a lack of phase separation.  This is 
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consistent with the observations of Daamen et al. and Buttafoco et al. (Daamen et al. 
2003; Buttafoco et al. 2005).    
 
The tensile properties of the myocardium have been recorded over a range of values: 
stiffness at diastole (E=10–20 kPa) or systole (E=50–200 kPa (Nagueh et al. 2004; 
Alter et al. 2008; Engelmayr et al. 2008; Zhong et al. 2009; Wang et al. 2010)).  The 
measured values of scaffold Young’s modulus varied within this range depending on 
composition (Table 4).  The addition of elastin to both collagen and gelatin scaffolds 
resulted in a slight increase in elongation at yield (in both tension and compression), 
which is expected due to its intrinsic elasticity.  The tensile stress-strain curve of 
collagen-soluble elastin also closely matched that of the myocardium, which may be 
due to the loss of soluble elastin resulting in a scaffold with overall reduced collagen 
content.  Collagen-insoluble elastin shows greater promise for use at high strains and 
would be preferable to one containing soluble elastin as the elastin is retained within 
the structure.     
 
Since the pore size for the crosslinked scaffolds of different compositions is similar 
(130–160 µm, Table 2), and did not change throughout the duration of the swelling 
study (results not shown), it is expected that the uptake of PBS into the structure is 
similar for scaffolds of different composition. However, there was a slight increase in 
material and bulk fluid uptake by collagen-based scaffolds containing elastin 
compared with those not containing elastin, which may be as a result of the more 
hydrophilic nature of elastin.  This was not the case for gelatin-based scaffolds, where 
the fluid uptake was similar for all compositions.  It is likely that gelatin coats elastin, 
preventing additional swelling of the material.  
 
Degradation studies in PBS demonstrated that the mass loss and change in 
compressive properties are dependent on the scaffold base composition and 
crosslinking. The stiffness of the scaffolds decreased after a time period of 10–
14 days, closely matching the increasing loss of mass.  Collagen containing insoluble 
elastin showed similar mass loss and compressive modulus to that of collagen, 
whereas collagen-soluble elastin had a significantly reduced compressive modulus; 
probably due to the loss of soluble elastin on crosslinking.  In the case of gelatin, the 
layer of insoluble elastin fibres at the scaffold bottom are unlikely to have provided 
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any compressive stiffness, giving a lower modulus than pure gelatin.  Where soluble 
elastin is present, scaffolds also appears to have a reduced compressive stiffness, 
possibly due to a reduced gelatin content and less stiff soluble elastin. 
 
This is part of a larger programme of research that aims to first characterise scaffolds 
in terms of their bulk physical properties before investigating these properties at a 
cellular level.  Although we have established that the composition most suitable for 
myocardial tissue engineering, in terms of morphological, mechanical and 
degradation properties, is one consisting of collagen (type I) containing insoluble 
elastin or gelatin and crosslinked, the exact composition can be tailored to match the 
properties of other soft tissues and be used in a wide range of applications.  While the 
bulk properties are known, the properties at a cellular level still need to be 
investigated.  Current investigations into the properties of thin films of these materials 
as well as their cell activity are underway, with the aim of producing a scaffold for 
use in soft tissue engineering that can be tailored to match both the bulk physical 
properties and remain biologically active.   
 
5. Conclusion 
In summary, varying the composition of a collagen- or gelatin-based scaffold 
alongside the use of crosslinking allows the physical properties to be better matched 
to those of the native heat tissue and show promise for use in other soft tissue 
engineering applications.  Crosslinking is required for mechanical strength, enhanced 
fluid retention and degradation resistance, providing a scaffold with increased 
structural integrity.  In using gelatin as a base-protein instead of collagen, the 
mechanical strength and stiffness and degradation resistance decreased, and therefore 
pure gelatin may be a suitable alternative to collagen for use in applications that 
require reduced stiffness and faster degradation rates e.g. skin repair.  The addition of 
insoluble elastin to collagen scaffolds to mimic properties of type III collagen was 
successful in terms of mechanical and degradation properties.  However, soluble 
elastin would not be recommended for future study, as a substantial proportion of the 
soluble elastin appeared to be lost during the crosslinking process.  The combination 
of collagen and gelatin resulted in a scaffold that showed optimal mechanical and 
degradation properties.  We have shown that varying the composition and cross-
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linking of scaffolds allows their bulk properties to be altered and thus indicates they 
can be tailored to better suit their use in specific soft tissue engineering applications. 
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Figure Captions 
Table 1 Scaffold compositions and abbreviations. 
Table 2 Morphological characteristics of the centre of scaffolds pre- and post-
crosslinking.  Note: * indicates statistically significant difference in comparison to 
non-crosslinked sample of same composition for statistical significance of p  ≤ 0.05 in 
Student’s t-test, (n=10, data are mean ± SEM*).  
Figure 1 Representative diagrams of component (phase) interactions in scaffolds; a) 
Coll, b) Coll-IE, c) Coll-SE, d) Gel, e) Gel-IE, f) Gel-SE and g) Coll-Gel.  Collagen is 
represented by thick black fibres (indicating tensile strength), gelatin is dashed-line 
fibres (weaker and more easily dissolved), insoluble elastin fibres are thick and 
yellow, while soluble elastin is thinner and blue. IE mixes well with Coll and SE 
mixes well with Gel, whereas IE sinks in Gel scaffolds and SE forms globules on Coll 
fibres. Coll-Gel shows effective mixing. 
Figure 2 SEM images of the cross-section and surfaces of a crosslinked collagen 
scaffold. a) Top, b) middle, c) bottom, d) top surface, e) bottom surface. Scale bar is 
1mm.  
Figure 3 SEM images of a) Coll-IE XL and b) Gel-IE XL scaffolds. a) Cross-section 
of the Coll-IE XL scaffold indicating a good interaction between elastin and collagen 
fibres; the collagen enwraps and bridges the elastin fibres. b) Base surface of the Gel-
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IE XL scaffold, showing clumps of large elastin fibres that have not formed a 
homogeneous phase with the gelatin, but have instead sunk to the bottom of the 
scaffold. Scale bar is 10 μm.  
Figure 4 SEM images of a) Coll-SE nX, b) Coll-SE XL and c) Gel-SE XL scaffolds. 
a) Arrows mark globules of soluble elastin, coating the collagen fibres, b) arrows 
point out the globules of soluble elastin that remain after crosslinking and c) single 
phase gelatin-soluble elastin scaffold. Scale bar is 10 μm.  
Table 3 Number of moles of free amine groups per gram of film (x 105) in non- and 
crosslinked films and calculated degree of crosslinking.  Note: * indicates statistically 
significant difference in comparison to non-crosslinked sample of same composition 
and ? indicates significant difference between compositions for statistical significance 
of p  ≤ 0.05 (n = 4, data are mean ± SEM*).    
  
Figure 5 Stress-strain curves in the physiological strain-regime for hydrated, 
crosslinked scaffolds tested in tension at 6 mm min-1 at room temperature. Three 
distinct regions: the toe, linear and failure regions can be identified. a) Collagen-based 
and mixed scaffolds, b) gelatin-based scaffolds. Representative uniaxial tensile stress-
strain curve for full thickness left ventricular human myocardium (heart tissue) also 
shown (Nagueh, Shah et al. 2004). 
Table 4 Mechanical Properties of crosslinked scaffolds, hydrated and tested in 
tension at 6 mm min-1 at room temperature and native myocardium (data obtain from 
(Nagueh, Shah et al. 2004; Alter, Rupp et al. 2008; Engelmayr, Cheng et al. 2008; 
Wang, Borazjani et al. 2010)).  Note: ? indicates significant difference between 
compositions (collagen-based and gelatin-based) for statistical significance of 
p  ≤ 0.05 (n = 9–12, data are mean ± SEM*). 
Figure 6 Stress-strain curves for hydrated, crosslinked scaffolds tested in 
compression at 6 mm min-1 at room temperature.  Distinct collapse plateau and 
densification regimes can be identified.  
Figure 7 Comparison of fluid uptake of scaffolds of different composition and 
crosslinking.  Time point data (graphs a and c) represent fluid uptake of the scaffold 
material after removal of pore water, and single column data (graphs b and d) 
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represent average fluid uptake of the scaffold as whole. a and b) Non-crosslinked and 
crosslinked collagen scaffolds, c and d) Collagen and Gelatin scaffolds. Note: * 
indicates statistically significant difference in comparison to non-crosslinked sample 
of same composition for statistical significance of p  ≤ 0.05 in Student’s t-test, (n=4, 
data are mean ± SEM*).   
Figure 8 Mass loss (a) and compressive modulus (b) of crosslinked scaffolds 
incubated in PBS at 37ºC for time period indicated, tested at 6 mm min-1.  Note: * 
indicates statistically significant difference in comparison to compressive modulus 
after 1 hour of scaffolds of the same composition for statistical significance of 
p  ≤ 0.05 in Student’s t-test, (n=4, data are mean ± SEM*).   
Figure 9 SEM image of HT1080 cells seeded in a crosslinked collagen-gelatin 
scaffold after culture for 3 days. Scale bars are a) 100 μm, b) 20 μm. 
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Figures 
Table 1  
Composition 
Abbreviation         
Non-Crosslinked 
Abbreviation 
Cross-linked 
Collagen  Coll nX Coll XL 
Collagen + insoluble elastin (ratio 9:1) Coll-IE nX Coll-IE XL 
Collagen + soluble elastin (ratio 9:1) Coll-SE nX Coll-SE XL 
Gelatin Gel nX Gel XL 
Gelatin + insoluble elastin (ratio 9:1) Gel-IE nX Gel-IE XL 
Gelatin + soluble elastin (ratio 9:1) Gel-SE nX Gel-SE XL 
Collagen + Gelatin (ratio 1:1) Coll-Gel nX Coll-Gel XL 
 
Table 2  
Composition Porosity (%) Pore Size (µm) Shrinkage (%) Mass Loss (%) 
Coll nX 92 190 ± 20     
Coll XL 70 * 160 ± 10 * 19 2 
          
Coll-IE nX 90 190 ± 20     
Coll-IE XL 78 * 160 ± 20 14 4 
          
Coll-SE nX 88 180 ± 10     
Coll-SE XL 66 * 150 ± 15 * 19 11 
          
Gel nX 85 150 ± 10     
Gel XL 69 * 130 ± 10 11 0 
          
Gel-IE nX 84 160 ± 10     
Gel-IE XL 68 * 150 ± 15 15 1 
          
Gel-SE nX 84 180 ± 10     
Gel-SE XL 65 * 160 ± 20 12 2 
          
Coll-Gel nX 88 180 ± 20     
Coll-Gel XL 73 * 150 ± 20 22 3 
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Figure 3  
 
 
 Figure 4  
 
 
Table 3  
  Uncross-linked Cross-linked Degree of Cross-linking 
Coll 11 ± 0.27 4.5 ± 0.47 * 0.60 ± 0.14 
Coll-IE 16 ± 0.70 8.6 ± 0.26 * 0.46 ± 0.08 
Coll-SE 13  ± 0.54 6.3 ± 0.45 * 0.52 ± 0.12 
Gel 21 ± 0.59       ? 8.4 ± 0.43 * 0.60 ± 0.06       ? 
Gel-IE 25 ± 0.47       ? 6.2 ± 0.37 * 0.75 ± 0.06       ? 
Gel-SE 21 ± 0.60       ? 4.5 ± 0.71 * 0.78 ± 0.09       ? 
Coll-Gel 20 ± 0.47       ? 7.3 ± 0.28 * 0.64 ± 0.04 
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Figure 5  
 
 
Table 4 
  Strain at Failure 
Stress at 20% Strain 
(kPa) 
Youngs Modulus at  20% 
Strain (kPa) 
Native Myocardium - 4-20 24-150 
        
Coll XL 0.32 ±  0.01 7.8 ±  0.9       ? 81 ±  8       ? 
Coll-IE XL 0.33 ±  0.03 4.5 ±  0.8       ? 45 ±  9       ? 
Coll-SE XL 0.41 ±  0.02 2.6 ±  0.2       ? 27 ±  2       ? 
Gel XL 0.27 ±  0.05 0.75 ±  0.11 4.6 ±  0.1 
Gel-IE XL 0.39 ±  0.03 0.77 ±  0.10 6 ± 1 
Gel-SE XL 0.42 ±  0.03 0.36 ± 0.05 2.4 ±  0.2 
Coll-Gel XL 0.42 ±  0.03 2.1 ±  0.3       ? 19 ±  3       ? 
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Figure 8  
 
 
Figure 9  
 
 
 
 
